Matthew Hewitt

Executive Director, Scientific Services, Cell & Gene Therapy (CGT) • Charles River

Matthew Hewitt, PhD, currently serves as the Executive Director, Scientific Services, Cell & Gene Therapy (CGT) at Charles River Laboratories (CRL). In this role, Matt leads one of Charles River’s CGT CDMO sites in helping partners move assets to clinic and commercial. Matt is also responsible for leading conversations on CRL’s cell and gene therapy strategic approach

Also Speaking

Ronit Slotky

Director, Cell Therapy Manufacturing Facility • Hackensack University Medical Center

Marco Ruella

Assistant Professor of Medicine in the Division of Hematology/Oncology and the Center for Cellular Immunotherapies • University of Pennsylvania

Xavier De Mollerat Du Jeu

Senior Director of Research and Development • Thermo Fisher Scientific Inc

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.